Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon? Archives of dermatology [Arch Dermatol] Journal article

Title	Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
Author(s)	Stichenwirth M, Riedl E, Pehamberger H, Tappeiner G
Source	Arch Dermatol 2008 Jun; 144(6):817-8.
MeSH	Adult Antibodies, Monoclonal Antirheumatic Agents Arthritis, Rheumatoid Autoantibodies Female Follow-Up Studies Humans Injections, Subcutaneous Pyoderma Gangrenosum Treatment Failure Tumor Necrosis Factor-alpha
Language	eng
Pub Type(s)	Case Reports Letter
PubMed ID	18559788

Advertise on this site.